Martin S. Little

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Anti-CMV IgG titer determines organ-specific protection toward immune checkpoint blockade-induced toxicities.

Anti-CMV IgG titer determines organ-specific protection toward immune checkpoint blockade-induced toxicities.

Journal: Journal for immunotherapy of cancer

Published: July 27, 2026

Lactation, tissue-resident immunity, and protection against breast cancer.

Lactation, tissue-resident immunity, and protection against breast cancer.

Journal: Trends in immunology

Published: December 08, 2025

The immunomodulatory role of human cytomegalovirus in cancer in the era of checkpoint immunotherapy.

The immunomodulatory role of human cytomegalovirus in cancer in the era of checkpoint immunotherapy.

Journal: Philosophical transactions of the Royal Society of London. Series B, Biological sciences

Published: November 06, 2025

Defining the genetic determinants of CD8+ T cell receptor repertoire in the context of immune checkpoint blockade.

Defining the genetic determinants of CD8+ T cell receptor repertoire in the context of immune checkpoint blockade.

Journal: Science advances

Published: July 25, 2025

CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockade.

CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockade.

Journal: Nature medicine

Published: December 23, 2024

Safe prescribing in cancer patients during the COVID-19 pandemic and outcomes following restart of cancer care following SARS-CoV-2 infection: The COV-SPOT initiative.

Safe prescribing in cancer patients during the COVID-19 pandemic and outcomes following restart of cancer care following SARS-CoV-2 infection: The COV-SPOT initiative.

Journal: International journal of cancer

Published: March 22, 2024

UK cancer vaccine advance - Recognising and realising opportunities.

UK cancer vaccine advance - Recognising and realising opportunities.

Journal: Cambridge prisms. Precision medicine

Published: October 10, 2023

A population-scale temporal case-control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP).

A population-scale temporal case-control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP).

Journal: Scientific reports

Published: February 03, 2023

Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional Evaluation.

Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional Evaluation.

Journal: JAMA oncology

Published: December 22, 2022

The National COVID Cancer Antibody Survey: a hyper-accelerated study proof of principle for cancer research.

The National COVID Cancer Antibody Survey: a hyper-accelerated study proof of principle for cancer research.

Journal: British journal of cancer

Published: December 12, 2022

Safe prescribing in cancer patients during the COVID-19 pandemic: A new initiative from the UK Cancer Coronavirus Project (UKCCP) team.

Safe prescribing in cancer patients during the COVID-19 pandemic: A new initiative from the UK Cancer Coronavirus Project (UKCCP) team.

Journal: International journal of cancer

Published: November 02, 2022

COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study.

COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 15, 2022

Showing 1-12 of 18

Last Updated: 09/26/2026